In agreement with the above observations, miRNA-222 mimics can promote resistance to adriamycin and docetaxol in MCF-7 breast cancer cells, with PTEN identified as the putative target of miRNA-222 [98]. The gene discussed is PTEN; the disease is breast cancer.